The global IVF devices and consumables market size reached USD 3.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.9 Billion by 2033, exhibiting a growth rate (CAGR) of 12.11% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 3.0 Billion |
Market Forecast in 2033
|
USD 8.9 Billion |
Market Growth Rate (2025-2033) | 12.11% |
In vitro fertilization (IVF) is an assisted reproductive technology (ART) that helps with fertility, prevents genetic problems, and assists in the conception of a child. It comprises several medicines and surgical procedures for ovulation, egg retrieval, insemination and fertilization, and embryo culture and transfer. It also helps in achieving a successful pregnancy and healthy baby in women with blocked or damaged fallopian tubes. In addition, it aids in male infertility problems by using intra-cytoplasmic sperm injection (ICSI) for conceiving. At present, there is a rise in the utilization of IVF devices and consumables, such as instruments, accessories and disposable, and reagents and media, on account of the increasing rate of infertility across the globe.
The rising awareness among the masses about the benefits of using IVF devices and consumables for a successful pregnancy represents one of the key factors propelling the market growth. Besides this, there is an increase in the number of delayed pregnancies worldwide. This, along with the burgeoning healthcare industry, is contributing to the growth of the market. Moreover, the rising number of gamete donations around the world to help intended parents have a child is offering lucrative growth opportunities to industry investors. In addition, governments of several countries are extensively investing in healthcare infrastructures, which is positively influencing the market. Apart from this, key market players are financing research and development (R&D) activities for improving embryo culture and cryopreservation and in vitro maturation. They are also focusing on several marketing strategies to increase their customer base. Additionally, the integration of artificial intelligence (AI) in IVF for the identification of an embryo is bolstering the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global IVF devices and consumables market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on product, technology and end user.
Breakup by Product:
Breakup by Technology:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Coopersurgical Inc. (The Cooper Companies Inc), Esco Medical, FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation), Genea Biomedx, Hamilton Thorne Ltd., INVO Bioscience, Memmert GmbH + Co.KG, Merck KGaA, Nidacon International AB, Rocket Medical Plc, Thermo Fisher Scientific and Vitrolife.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Product, Technology, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Coopersurgical Inc. (The Cooper Companies Inc), Esco Medical, FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation), Genea Biomedx, Hamilton Thorne Ltd., INVO Bioscience, Memmert GmbH + Co.KG, Merck KGaA, Nidacon International AB, Rocket Medical Plc, Thermo Fisher Scientific and Vitrolife |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global IVF devices and consumables market was valued at USD 3.0 Billion in 2024.
We expect the global IVF devices and consumables market to exhibit a CAGR of 12.11% during 2025-2033.
The rising number of delayed pregnancies, along with the increasing adoption of IVF devices and consumables, such as instruments, accessories and disposable, reagents and media, etc., is primarily driving the global IVF devices and consumables market.
The sudden outbreak of the COVID-19 pandemic had led to postponement of elective IVF procedures to reduce the risk of the coronavirus infection upon hospital visits and interaction with medical equipment, thereby negatively impacting the global market for IVF devices and consumables.
Based on the product, the global IVF devices and consumables market can be categorized into instruments, accessories and disposables, and reagents and media. Currently, accessories and disposables hold the majority of the total market share.
Based on the technology, the global IVF devices and consumables market has been segregated into fresh embryo IVF, frozen embryo IVF, and donor egg IVF. Among these, fresh embryo IVF currently exhibits a clear dominance in the market.
Based on the end user, the global IVF devices and consumables market can be bifurcated into fertility clinics, hospitals, surgical centers, and clinical research institutes. Currently, fertility clinics account for the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global IVF devices and consumables market include Coopersurgical Inc. (The Cooper Companies Inc), Esco Medical, FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation), Genea Biomedx, Hamilton Thorne Ltd., INVO Bioscience, Memmert GmbH + Co.KG, Merck KGaA, Nidacon International AB, Rocket Medical Plc, Thermo Fisher Scientific, and Vitrolife.